Related Content
April 3, 2019 โ The U.S. Food and Drug Administration (FDA) recently granted an additional indication to Bard Peripheral ...
April 03, 2019
April 3, 2019 โ The U.S. Food and Drug Administration (FDA) recently cleared Bard Peripheral Vascular's Venovo Venous ...
April 03, 2019
January 31, 2017 โ Bard Peripheral Vascular Inc. is recalling the Halo One Thin-Walled Guiding Sheath because the sheath ...
January 31, 2017
In 2015, the FDA approved the first two drug-coated balloons for the U.S. market to treat peripheral artery disease in ...
April 02, 2015
Feature | Drug-Eluting Balloons| Dave Fornell
Drug-eluting balloons (DEBs), also referred to as drug-coated balloons (DCBs), have been one of the long-awaited new ...
February 19, 2015
January 30, 2015 โ ECRI Institute has created a report that offers an overview of drug-eluting balloon (DEB) technology ...
January 30, 2015October 31, 2014 โ Metro Health (Michigan) cardiovascular specialist Jihad Mustapha, M.D., is one of the first ...
October 31, 2014
January 6, 2012 - C. R. Bard recently announced it acquired drug-eluting balloon maker Lutonix Inc. for $225 million ...
January 06, 2012
Feature | Dave Fornell
There have been several key news items from the U.S. stent market over the past year. These include the introduction of ...
September 26, 2011
January 27, 2010 โ The U.S. Food and Drug Administration (FDA) expanded the indication for the Bard Peripheral Vascular ...
January 27, 2011